Literature DB >> 21751365

Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants.

Olgica Trenchevska1, Elena Kamcheva, Dobrin Nedelkov.   

Abstract

Transthyretin (TTR, or prealbumin) is a tetrameric protein found in plasma and cerebrospinal fluid. Its major role is to transport thyroid hormones (thyroxin-T4) and retinol (through association with retinol-binding protein). TTR has been studied extensively due to the great number of point mutations that result in sequence heterogeneity. Many of these variants are associated with pathological conditions that result in extracellular deposition of amyloid fibers in tissues. In this work, we have developed a rapid mass spectrometric immunoassay for determination and quantification of TTR and its variants from human serum and plasma samples. The assay was fully characterized in terms of its precision, linearity and recovery characteristics. The new assay was also compared with a conventional TTR ELISA. Furthermore, we have applied the optimized method to analyze TTR and its modifications in 44 human plasma samples, and in the process optimized a method for TTR proteolytic digestion and identification of point mutations.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21751365      PMCID: PMC4599786          DOI: 10.1002/pmic.201100023

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  39 in total

Review 1.  Transthyretin amyloidosis: a tale of weak interactions.

Authors:  M J Saraiva
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

2.  The peak height ratio of S-sulfonated transthyretin and other oxidized isoforms as a marker for molybdenum cofactor deficiency, measured by electrospray ionization mass spectrometry.

Authors:  Masahiko Kishikawa; Jörn Oliver Sass; Nobuo Sakura; Toyofumi Nakanishi; Akira Shimizu; Masanori Yoshioka
Journal:  Biochim Biophys Acta       Date:  2002-11-20

Review 3.  The evolution of gene expression, structure and function of transthyretin.

Authors:  G Schreiber; S J Richardson
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1997-02       Impact factor: 2.231

4.  An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing.

Authors:  N J Fitch; M T Akbari; D B Ramsden
Journal:  J Endocrinol       Date:  1991-05       Impact factor: 4.286

Review 5.  Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies.

Authors:  A M Damas; M J Saraiva
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

6.  The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution.

Authors:  A Quintas; M J Saraiva; R M Brito
Journal:  FEBS Lett       Date:  1997-12-01       Impact factor: 4.124

7.  Biochemical and clinical characterization of prealbuminCHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis.

Authors:  H H Harrison; E D Gordon; W C Nichols; M D Benson
Journal:  Am J Med Genet       Date:  1991-06-15

Review 8.  Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.

Authors:  Maria João Saraiva; Mónica Mendes Sousa; Isabel Cardoso; Rui Fernandes
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.

Authors:  Yutaka Takaoka; Mika Ohta; Kazuhisa Miyakawa; Osamu Nakamura; Misao Suzuki; Kiyoshi Takahashi; Ken-Ichi Yamamura; Yoshiyuki Sakaki
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

10.  Tabulation of human transthyretin (TTR) variants, 2003.

Authors:  Lawreen Heller Connors; Amareth Lim; Tatiana Prokaeva; Violet A Roskens; Catherine E Costello
Journal:  Amyloid       Date:  2003-09       Impact factor: 7.141

View more
  14 in total

1.  Efficient sample preparation in immuno-matrix-assisted laser desorption/ionization mass spectrometry using acoustic trapping.

Authors:  Björn Hammarström; Hong Yan; Johan Nilsson; Simon Ekström
Journal:  Biomicrofluidics       Date:  2013-03-28       Impact factor: 2.800

Review 2.  Mass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.

Authors:  Olgica Trenchevska; Randall W Nelson; Dobrin Nedelkov
Journal:  Bioanalysis       Date:  2016-07-11       Impact factor: 2.681

3.  Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms.

Authors:  Olgica Trenchevska; Matthew R Schaab; Randall W Nelson; Dobrin Nedelkov
Journal:  Methods       Date:  2015-03-07       Impact factor: 3.608

4.  Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.

Authors:  Jiong Chen; Long-Jiang Chen; Yun-Lian Xia; Hang-Cheng Zhou; Ren-Bao Yang; Wen Wu; Yin Lu; Li-Wei Hu; Yue Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-02       Impact factor: 4.553

5.  Development of quantitative mass spectrometric immunoassay for serum amyloid A.

Authors:  Olgica Trenchevska; Hussein N Yassine; Chad R Borges; Randall W Nelson; Dobrin Nedelkov
Journal:  Biomarkers       Date:  2016-07-22       Impact factor: 2.658

6.  Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides.

Authors:  Romain Simon; Marion Girod; Catherine Fonbonne; Arnaud Salvador; Yohann Clément; Pierre Lantéri; Philippe Amouyel; Jean Charles Lambert; Jérôme Lemoine
Journal:  Mol Cell Proteomics       Date:  2012-08-23       Impact factor: 5.911

7.  Transthyretin variants with improved inhibition of β-amyloid aggregation.

Authors:  Parth Mangrolia; Dennis T Yang; Regina M Murphy
Journal:  Protein Eng Des Sel       Date:  2016-04-19       Impact factor: 1.650

Review 8.  Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Authors:  Hussein Yassine; Chad R Borges; Matthew R Schaab; Dean Billheimer; Craig Stump; Peter Reaven; Serrine S Lau; Randall Nelson
Journal:  Proteomics Clin Appl       Date:  2013-07-09       Impact factor: 3.494

9.  Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.

Authors:  Olgica Trenchevska; Nisha D Sherma; Paul E Oran; Peter D Reaven; Randall W Nelson; Dobrin Nedelkov
Journal:  J Proteomics       Date:  2014-12-27       Impact factor: 4.044

10.  Advantageous uses of mass spectrometry for the quantification of proteins.

Authors:  John E Hale
Journal:  Int J Proteomics       Date:  2013-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.